tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
Altamira Therapeutics (CYTO)
NASDAQ:CYTO
US Market
CYTO
Altamira Therapeutics
Stock Analysis
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding CYTO?
Track your performance easily
Link Broker

Altamira Therapeutics (CYTO) Stock Forecast & Price Target

598 Followers
See the Price Targets and Ratings of:

CYTO Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Altamira
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CYTO Stock 12 Month Forecast

There Are No Analyst Ratings for CYTO In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

CYTO Financial Forecast

CYTO Earnings Forecast

Next quarter’s earnings estimate for CYTO is -$0.57 with a range of -$0.57 to -$0.57. The previous quarter’s EPS was -$2.00. CYTO beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.92% of the time in the same period. In the last calendar year CYTO has Outperformed its overall industry.
Next quarter’s earnings estimate for CYTO is -$0.57 with a range of -$0.57 to -$0.57. The previous quarter’s EPS was -$2.00. CYTO beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.92% of the time in the same period. In the last calendar year CYTO has Outperformed its overall industry.

CYTO Sales Forecast

Next quarter’s sales forecast for CYTO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CYTO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.51% of the time in the same period. In the last calendar year CYTO has Underperformed its overall industry.
Next quarter’s sales forecast for CYTO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. CYTO beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.51% of the time in the same period. In the last calendar year CYTO has Underperformed its overall industry.

CYTO Analyst Recommendation Trends

Rating
Jul 16
Aug 16
Nov 16
Jun 17
Oct 18
Strong Buy
0
0
0
0
0
Buy
5
6
4
4
3
Hold
0
1
2
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
7
6
6
4
In the current month, CYTO has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CYTO average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

CYTO Stock Forecast FAQ

What is CYTO’s average 12-month price target, according to analysts?
Currently, no data Available
What is CYTO’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CYTO, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is CYTO a Buy, Sell or Hold?
      Currently, no data Available
      What is Altamira Therapeutics’s price target?
      Currently, no data Available
      What do analysts say about Altamira Therapeutics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of CYTO?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing